Skip to main content
Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
5.81
+0.18 (3.20%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Lexeo Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
59
Market Cap
430.45M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025---
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022654.00K-1.00M-60.53%
Dec 31, 20211.66M1.14M219.59%
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Vanda Pharmaceuticals 216.11M
Niagen Bioscience 129.42M
Century Therapeutics 109.16M
Assembly Biosciences 72.30M
Invivyd 53.43M
PureTech Health 6.39M
Armata Pharmaceuticals 4.90M
Neurogene 925.00K
Revenue Rankings

LXEO News

More News